p73, like its p53 homolog, shows preference for inverted repeats forming cruciforms

PLoS One. 2018 Apr 18;13(4):e0195835. doi: 10.1371/journal.pone.0195835. eCollection 2018.

Abstract

p73 is a member of the p53 protein family and has essential functions in several signaling pathways involved in development, differentiation, DNA damage responses and cancer. As a transcription factor, p73 achieves these functions by binding to consensus DNA sequences and p73 shares at least partial target DNA binding sequence specificity with p53. Transcriptional activation by p73 has been demonstrated for more than fifty p53 targets in yeast and/or human cancer cell lines. It has also been shown previously that p53 binding to DNA is strongly dependent on DNA topology and the presence of inverted repeats that can form DNA cruciforms, but whether p73 transcriptional activity has similar dependence has not been investigated. Therefore, we evaluated p73 binding to a set of p53-response elements with identical theoretical binding affinity in their linear state, but different probabilities to form extra helical structures. We show by a yeast-based assay that transactivation in vivo correlated more with the relative propensity of a response element to form cruciforms than to its expected in vitro DNA binding affinity. Structural features of p73 target sites are therefore likely to be an important determinant of its transactivation function.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Base Sequence
  • Binding Sites*
  • Humans
  • Inverted Repeat Sequences*
  • Nucleic Acid Conformation
  • Protein Binding
  • Transcriptional Activation
  • Tumor Protein p73 / chemistry
  • Tumor Protein p73 / genetics
  • Tumor Protein p73 / metabolism*
  • Tumor Suppressor Protein p53 / metabolism
  • Yeasts / genetics
  • Yeasts / metabolism

Substances

  • Tumor Protein p73
  • Tumor Suppressor Protein p53

Grants and funding

This work was supported by the Grant Agency of the Czech Republic (15-21855S, 18-15548S) and by the SYMBIT project reg. no. CZ.02.1.01/0.0/0.0/15_003/0000477 financed from the ERDF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.